Publication date: Sep 16, 2024
Several studies have shown that pulmonary telerehabilitation (PTR) improves respiratory capacity. However, there is little evidence of its effectiveness in youth with post-COVID-19 conditions (PCC). This study analyzed the effects of a PTR program on young adults with PCC. Sixteen youths were randomly assigned to a control group (CG) or an experimental group (EG), with eight participants each. The EG participated in a PTR program that included twelve remote, asynchronous four-week sessions with diaphragmatic breathing and aerobic exercises. Vital signs (SpO, HR, RR, BP), physical capacity (sit-to-stand test), cardiorespiratory capacity (6-Minute Walk Test), and perceived exertion (Borg scale) were assessed in both groups. Statistical analyses showed a significant decrease in RR and HR (p < 0. 012) and an increase in SpO (p < 0. 042), physical (p < 0. 012), and respiratory (p < 0. 028) capacity. Perceived effort decreased significantly in both groups (CG: p < 0. 006; EG: p < 0. 001) only for physical but not for cardiorespiratory capacity (p < 0. 106). There were no statistical changes registered in BP (p > 0. 05). The PTR program, which includes respiratory and aerobic exercises, is feasible and effective in improving physical and cardiorespiratory capacity in young people with PCC, as well as reducing HR, RR, and dyspnea.
Open Access PDF
Concepts | Keywords |
---|---|
Cardiorespiratory | aerobic exercises |
Healthcare | COVID-19 |
Improving | pulmonary rehabilitation |
Pilot | telerehabilitation |
Week | young adults |
Semantics
Type | Source | Name |
---|---|---|
drug | DRUGBANK | Factor IX Complex (Human) |
disease | MESH | dyspnea |
disease | MESH | COVID 19 |
disease | MESH | viral infection |
disease | MESH | chest pain |
drug | DRUGBANK | Coenzyme M |
disease | MESH | infection |
disease | IDO | immune response |
disease | MESH | oxidative damage |
disease | IDO | intervention |
disease | MESH | pulmonary diseases |
drug | DRUGBANK | Oxygen |
disease | IDO | blood |
disease | MESH | dissociation |
disease | IDO | process |
disease | MESH | sequelae |
disease | IDO | symptom |
drug | DRUGBANK | Trestolone |
disease | MESH | chronic conditions |
disease | MESH | long covid |
drug | DRUGBANK | (S)-Des-Me-Ampa |
drug | DRUGBANK | Sulfasalazine |
disease | MESH | syndrome |
drug | DRUGBANK | D-Alanine |
disease | MESH | heart failure |
disease | MESH | COPD |